Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Right To Try' And PDUFA VI: Patient Advocates, Industry Fight Senate Add-On

May 03 2017

• By Kate Rawson

Capitol House

Related Content

First Draft FDA User Fee Bill Is Squeaky Clean

Apr 14 2017

Gottlieb Advances, But FDA's Future Seems Increasingly Partisan

Apr 27 2017

Gottlieb Q&A: Off-Label Communications And Right-To-Try

May 03 2017

'Right to Try' Has White House Support: Add-On To PDUFA Looks Tough To Stop

Feb 10 2017

Chimerix And FDA’s Compassionate-Use Solution

Mar 26 2014

'Right To Try' Bill Contradicts US FDA’s Mission, Former Official Says

Mar 14 2017

Expanded Access Programs Need FDA Policy Changes To Really Expand

May 23 2016

Bill Bonanza: US Congress Sprouts Medtech Legislation This Spring

May 02 2017

US FDA Plans New Office Of Patient Affairs

Mar 13 2017

Related Companies

Chimerix, Inc.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Legislation FDA Research & Development BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window